These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 37391812)

  • 1. Cancer metabolites: promising biomarkers for cancer liquid biopsy.
    Wang W; Rong Z; Wang G; Hou Y; Yang F; Qiu M
    Biomark Res; 2023 Jun; 11(1):66. PubMed ID: 37391812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prowess of metabolomics in cancer research: current trends, challenges and future perspectives.
    Taunk K; Jajula S; Bhavsar PP; Choudhari M; Bhanuse S; Tamhankar A; Naiya T; Kalita B; Rapole S
    Mol Cell Biochem; 2024 May; ():. PubMed ID: 38814423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer.
    Li S; Xin K; Pan S; Wang Y; Zheng J; Li Z; Liu X; Liu B; Xu Z; Chen X
    Cell Mol Biol Lett; 2023 Apr; 28(1):28. PubMed ID: 37016296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future applications of liquid biopsy in non-small-cell lung cancer-a narrative review.
    Tomasik B; Skrzypski M; Bieńkowski M; Dziadziuszko R; Jassem J
    Transl Lung Cancer Res; 2023 Mar; 12(3):594-614. PubMed ID: 37057121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microbiome DNA: An emerging paradigm for cancer liquid biopsy.
    Chen H; Ma Y; Liu Z; Li J; Li X; Yang F; Qiu M
    Cancer Lett; 2021 Aug; 521():82-87. PubMed ID: 34461180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites.
    Yue X; He J; Zhang R; Xu J; Zhou Z; Zhang R; Bi N; Wang Z; Sun C; Wang L; Chen Y; Abliz Z
    J Chromatogr A; 2018 Dec; 1580():80-89. PubMed ID: 30473010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Profiling and Metabolites Fingerprints in Human Hypertension: Discovery and Potential.
    Onuh JO; Qiu H
    Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer.
    Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; López-López R; Muinelo-Romay L; Diaz-Lagares A
    Front Cell Dev Biol; 2021; 9():622459. PubMed ID: 33614651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells in the early detection of human cancers.
    Feng Z; Wu J; Lu Y; Chan YT; Zhang C; Wang D; Luo D; Huang Y; Feng Y; Wang N
    Int J Biol Sci; 2022; 18(8):3251-3265. PubMed ID: 35637960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies.
    Chang L; Li J; Zhang R
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188729. PubMed ID: 35436521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To metabolomics and beyond: a technological portfolio to investigate cancer metabolism.
    Danzi F; Pacchiana R; Mafficini A; Scupoli MT; Scarpa A; Donadelli M; Fiore A
    Signal Transduct Target Ther; 2023 Mar; 8(1):137. PubMed ID: 36949046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy markers for early diagnosis of brain metastasis patients with breast cancer by metabolomics.
    Özer Ö; Nemutlu E; Reçber T; Eylem CC; Aktas BY; Kır S; Kars A; Aksoy S
    Eur J Mass Spectrom (Chichester); 2022 Feb; 28(1-2):56-64. PubMed ID: 35422172
    [No Abstract]   [Full Text] [Related]  

  • 15. High-throughput metabolomics for discovering metabolic biomarkers from intestinal tumorigenesis in APC
    Guo XD; Liu L; Xiao HY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():131-139. PubMed ID: 30316137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Microenvironment-Derived Metabolites: A Guide to Find New Metabolic Therapeutic Targets and Biomarkers.
    García-Cañaveras JC; Lahoz A
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of early and late stages of bladder cancer using metabolites and machine learning.
    Kouznetsova VL; Kim E; Romm EL; Zhu A; Tsigelny IF
    Metabolomics; 2019 Jun; 15(7):94. PubMed ID: 31222577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress on liquid biopsy in oncology and its clinical applications.
    Wang C; Li YM; Fang XD
    Yi Chuan; 2017 Mar; 39(3):220-231. PubMed ID: 28420618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biomarkers in melanoma: detection and discovery.
    Lim SY; Lee JH; Diefenbach RJ; Kefford RF; Rizos H
    Mol Cancer; 2018 Jan; 17(1):8. PubMed ID: 29343260
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.